PTGX vs XEL · rev $269.8M vs P/E 20, $39.33B cap
Protagonist Therapeutics Inc (PTGX) versus Xcel Energy Inc (XEL) — a side-by-side from cached financials, not a winner call.
Protagonist Therapeutics Inc (PTGX) is a biotechnology company listed on NASDAQ.
Xcel Energy Inc (XEL) is a utilities - regulated electric company listed on US.
Latest reported PTGX revenue for 2026-06-30 was $269.8M. Net income was $166.6M. PTGX currently screens at market cap $7.25B.
XEL does not have a complete income-statement cache yet.
PTGX currently screens at market cap $7.25B. XEL currently screens at market cap $39.33B and trailing P/E 20.1.
Not investment advice. Open the PTGX and XEL stock pages for the full models.
Not investment advice.